» Articles » PMID: 28979007

Emerging Infectious Diseases: Epidemiological Perspective

Overview
Specialty Dermatology
Date 2017 Oct 6
PMID 28979007
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Over the past 30 years, at least 30 new infectious diseases have emerged to threaten the health of millions of people across the globe. The major challenge to combat these infections is that for many of them, there is no specific treatment or cure or vaccine. There is limited scope of preventing or controlling them. The contributory factors include urbanization and destruction of natural habitats, climate change and changing ecosystems, changes in population of reservoir hosts or intermediate insect vectors and microbial genetic mutation, international trade and commerce, change in human demographics and behavior, lack of public health services and infrastructure, and antibiotic resistance. It is clear by now that the problem of emerging infectious disease (EID) is not restricted to any single country, and a strong and sustainable international collaboration will be needed in their prevention and control. India along with other countries in the South-East Asian region will continue to bear the brunt of the burden of EIDs in years to come.

Citing Articles

Socioeconomic and academic consequences of COVID-19 pandemic on medical students from the University of Rwanda.

Ndamukunda O, Mutuyimana M, Umubano F, Tuyishime E PLoS One. 2025; 20(2):e0318066.

PMID: 39946415 PMC: 11825058. DOI: 10.1371/journal.pone.0318066.


Knowledge, practice, and information sources regarding infectious diseases among Chinese children and adolescents: a National-Level cross-sectional study.

Zeng Y, Li F, Liang W, Liu Y, Zou Z, Baker J BMC Public Health. 2025; 25(1):412.

PMID: 39893404 PMC: 11787737. DOI: 10.1186/s12889-025-21516-x.


The COVID-19 Pandemic and the Resilience of the Pharmaceutical Supply Chain: Lessons from Past Experiences and Strategies for the Future.

Aivazi M, Rasekh H, Peikanpour M, Peiravian F, Esmaeili S, Zarei L Iran J Pharm Res. 2025; 23(1):e152723.

PMID: 39830650 PMC: 11742386. DOI: 10.5812/ijpr-152723.


How do host population dynamics impact Lyme disease risk dynamics in theoretical models?.

Savage J, Moore C PLoS One. 2024; 19(5):e0302874.

PMID: 38722910 PMC: 11081252. DOI: 10.1371/journal.pone.0302874.


Comparison of neutralization potency across passive immunotherapy approaches as potential treatments for emerging infectious diseases.

Ranjbaran H, Ehteshaminia Y, Nadernezhad M, Jalali S, Jadidi-Niaragh F, Pagheh A Heliyon. 2024; 10(1):e23478.

PMID: 38226283 PMC: 10788261. DOI: 10.1016/j.heliyon.2023.e23478.


References
1.
Gurav Y, Tandale B, Jadi R, Gunjikar R, Tikute S, Jamgaonkar A . Chandipura virus encephalitis outbreak among children in Nagpur division, Maharashtra, 2007. Indian J Med Res. 2010; 132:395-9. View

2.
Nath B, Mahanta T . Investigation of an outbreak of diphtheria in borborooah block of dibrugarh district, assam. Indian J Community Med. 2010; 35(3):436-8. PMC: 2963888. DOI: 10.4103/0970-0218.69282. View

3.
Mitra R, Basu A, Dutta D, Nair G, Takeda Y . Resurgence of Vibrio cholerae O139 Bengal with altered antibiogram in Calcutta, India. Lancet. 1996; 348(9035):1181. DOI: 10.1016/s0140-6736(05)65326-3. View

4.
Ramamurthy T, Yamasaki S, Takeda Y, Nair G . Vibrio cholerae O139 Bengal: odyssey of a fortuitous variant. Microbes Infect. 2003; 5(4):329-44. DOI: 10.1016/s1286-4579(03)00035-2. View

5.
Mackey T, Liang B, Cuomo R, Hafen R, Brouwer K, Lee D . Emerging and reemerging neglected tropical diseases: a review of key characteristics, risk factors, and the policy and innovation environment. Clin Microbiol Rev. 2014; 27(4):949-79. PMC: 4187634. DOI: 10.1128/CMR.00045-14. View